METLY is an AI-driven platform that enables pharmaceutical business development teams to discover and manage partnership opportunities efficiently through a centralized database. By streamlining the search for licenses, contract manufacturers, and distribution channels, METLY reduces the time required to launch new products.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical business development teams face challenges in efficiently discovering and managing partnership opportunities, often relying on traditional networking methods that can be time-consuming and may overlook potential deals. This can lead to delays in launching new products and limit portfolio expansion.
Solution
METLY is an AI-driven platform designed to streamline the process of discovering and managing pharmaceutical partnership opportunities. It provides a centralized database where business development teams can efficiently search for licenses, contract manufacturers, and distribution channels. The platform uses AI to recommend new products tailored to a company's portfolio, helping teams identify opportunities they might miss through traditional networking. METLY also facilitates communication and negotiation with potential partners in a centralized location, enabling effective tracking and management of opportunities to reduce the time required to launch new products.
Target Audience
The primary users are pharmaceutical business development teams seeking to expand their product portfolios and improve the efficiency of their partnership efforts.
Features
- AI-powered recommendations for product opportunities tailored to specific portfolios.
- Centralized database for licenses, contract manufacturers, and distribution channels.
- Integrated communication tools for direct engagement and negotiation with sellers.
- Opportunity tracking and management features to streamline the deal-making process.
- Search functionality to discover new products based on specific criteria.